Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
24.43-0.31 (-1.25%)
At close: 04:00PM EDT
24.28 -0.15 (-0.61%)
After hours: 05:44PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/31/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 351.11
52 Week Low 323.09
50-Day Moving Average 330.83
200-Day Moving Average 334.90

Share Statistics

Avg Vol (3 month) 31.12M
Avg Vol (10 day) 31.24M
Shares Outstanding 5106.71M
Implied Shares Outstanding 6N/A
Float 8104.96M
% Held by Insiders 14.93%
% Held by Institutions 167.91%
Shares Short (Jan 30, 2023) 44.58M
Short Ratio (Jan 30, 2023) 44.1
Short % of Float (Jan 30, 2023) 45.12%
Short % of Shares Outstanding (Jan 30, 2023) 44.29%
Shares Short (prior month Dec 29, 2022) 44.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Nov 16, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2022
Most Recent Quarter (mrq)Dec 30, 2022

Profitability

Profit Margin -55.51%
Operating Margin (ttm)-56.52%

Management Effectiveness

Return on Assets (ttm)-12.85%
Return on Equity (ttm)-40.43%

Income Statement

Revenue (ttm)278.34M
Revenue Per Share (ttm)2.63
Quarterly Revenue Growth (yoy)127.90%
Gross Profit (ttm)243.23M
EBITDA -146.78M
Net Income Avi to Common (ttm)-154.52M
Diluted EPS (ttm)-1.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)501.83M
Total Cash Per Share (mrq)4.63
Total Debt (mrq)82.13M
Total Debt/Equity (mrq)20.72
Current Ratio (mrq)4.71
Book Value Per Share (mrq)4.40

Cash Flow Statement

Operating Cash Flow (ttm)-150.34M
Levered Free Cash Flow (ttm)-137.91M
Advertisement
Advertisement